Suppr超能文献

经动脉化疗栓塞后肝细胞癌的细胞凋亡与再生

Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization.

作者信息

Li Zhen, Hu Dao-Yu, Chu Qian, Wu Jian-Hong, Gao Chun, Zhang Yu-Qing, Huang Yan-Rong

机构信息

Department of Radiology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.

出版信息

World J Gastroenterol. 2004 Jul 1;10(13):1876-80. doi: 10.3748/wjg.v10.i13.1876.

Abstract

AIM

To evaluate whether cell apoptosis and regeneration were existed in normal liver cells adjacent to carcinoma after transarterial chemoembolization (TACE).

METHODS

Fifty rabbits with hepatic carcinoma were divided into 5 groups at random: group A (control group), groups B and C (TACE treatment groups), groups D and E (partial hepatectomy groups). There were 10 rabbits in each group. Rabbits in groups B-E were treated by transarterial chemoembolization (TACE) and partial hepatectomy (PH) respectively. The changes of S-phase cell fraction (SPF), proliferation index (PI) and cell apoptosis in the normal liver tissue were determined with flow cytometry (FCM) after operations on the first and third days. We determined the mitosis index (MI) with histo-pathological method and the apoptosis index (AI) with TUNEL method at the same time.

RESULTS

Twenty-four hours after operations, compared with control group, the rabbits in TACE group had much higher index of SPF, PI and MI (MI: t=4.89, P<0.001; SPF:t=5.27, P<0.001; PI: t=4.87, P<0.001). Moreover, the proliferation of liver cells in TACE group was much weaker than that of the cells treated by partial hepatectomy, and the differences were significant (MI: t=7.02, P<0.001; SPF: t=4.06, P<0.001; PI: t=2.70, P<0.05). Seventy-two h after operations, FCM showed a small sub-G1 peak in TACE group and PH group, compared with the control group, but there was no difference between them (t=0.41, P>0.05). TACE showed that AI in the treated rabbits was higher than that in control group (t=3.07, P<0.05), and there were no differences between TACE group and PH group, either (t=0.93, P>0.05).

CONCLUSION

Cell apoptosis and regeneration exist in rabbit liver tissues after TACE in some degree, which may be associated with the selective embolization of iodised oil, chemotherapeutic drug and free radical damage.

摘要

目的

评估经动脉化疗栓塞术(TACE)后癌旁正常肝细胞是否存在细胞凋亡及再生。

方法

50只肝癌兔随机分为5组:A组(对照组)、B组和C组(TACE治疗组)、D组和E组(部分肝切除术组)。每组10只兔。B - E组兔分别接受经动脉化疗栓塞术(TACE)和部分肝切除术(PH)。术后第1天和第3天采用流式细胞术(FCM)检测正常肝组织中S期细胞分数(SPF)、增殖指数(PI)及细胞凋亡的变化。同时采用组织病理学方法测定有丝分裂指数(MI),采用TUNEL法测定凋亡指数(AI)。

结果

术后24小时,与对照组相比,TACE组兔的SPF、PI及MI指数明显更高(MI:t = 4.89,P < 0.001;SPF:t = 5.27,P < 0.001;PI:t = 4.87,P < 0.001)。此外,TACE组肝细胞的增殖明显弱于部分肝切除术组,差异有统计学意义(MI:t = 7.02,P < 0.001;SPF:t = 4.06,P < 0.001;PI:t = 2.70,P < 0.05)。术后72小时,FCM显示TACE组和PH组出现小的亚G1峰,与对照组相比,但两组间无差异(t = 0.41,P > 0.05)。TACE显示治疗兔的AI高于对照组(t = 3.07,P < 0.05),TACE组与PH组之间也无差异(t = 0.93,P > 0.05)。

结论

TACE术后兔肝组织存在一定程度的细胞凋亡及再生,这可能与碘化油的选择性栓塞、化疗药物及自由基损伤有关。

相似文献

1
Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization.
World J Gastroenterol. 2004 Jul 1;10(13):1876-80. doi: 10.3748/wjg.v10.i13.1876.
5
Transarterial chemoembolization using cisplatin powder in a rabbit model of liver cancer.
Cardiovasc Intervent Radiol. 2008 Sep-Oct;31(5):981-5. doi: 10.1007/s00270-008-9367-8. Epub 2008 Jun 6.
7
Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect.
J Vasc Interv Radiol. 2016 Jul;27(7):1086-92. doi: 10.1016/j.jvir.2016.02.032. Epub 2016 May 11.
10
Single-bolus regional chemotherapy with doxorubicin versus chemoembolization in a rabbit VX2 tumor model.
Diagn Interv Radiol. 2011 Dec;17(4):374-80. doi: 10.4261/1305-3825.DIR.4016-10.1. Epub 2011 Jan 10.

引用本文的文献

1
Janus Microcarriers for Magnetic Field-controlled Combination Chemotherapy of Hepatocellular Carcinoma.
Adv Funct Mater. 2019 Jun 27;29(26). doi: 10.1002/adfm.201901384. Epub 2019 Apr 30.
3
Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib.
J Hepatocell Carcinoma. 2023 Feb 15;10:257-266. doi: 10.2147/JHC.S396231. eCollection 2023.
4
Preclinical Therapeutic Evaluation of Lenvatinib-Eluting Microspheres for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Cardiovasc Intervent Radiol. 2022 Dec;45(12):1834-1841. doi: 10.1007/s00270-022-03242-8. Epub 2022 Aug 12.
5
Extracellular Vesicles Derived From Apoptotic Cells: An Essential Link Between Death and Regeneration.
Front Cell Dev Biol. 2020 Oct 2;8:573511. doi: 10.3389/fcell.2020.573511. eCollection 2020.
6
Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation.
J Am Coll Surg. 2017 Jul;225(1):28-40. doi: 10.1016/j.jamcollsurg.2017.03.015. Epub 2017 Apr 9.
7
The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular Carcinoma.
J Clin Med Res. 2016 Apr;8(4):297-302. doi: 10.14740/jocmr2496w. Epub 2016 Feb 27.
10
Effective therapeutic management of hepatocellular carcinoma - on the basis of a clinical case.
Contemp Oncol (Pozn). 2012;16(1):60-3. doi: 10.5114/wo.2012.27339. Epub 2012 Feb 29.

本文引用的文献

2
Supplemental transcatheter arterial chemoembolization through a collateral omental artery: treatment for hepatocellular carcinoma.
Cardiovasc Intervent Radiol. 2003 Mar-Apr;26(2):136-40. doi: 10.1007/s00270-002-2629-y. Epub 2003 Mar 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验